
Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global female sexual dysfunction treatment market size is expected to grow at a CAGR of 34.20% during the forecast period of 2025-2034 likely to be driven by the rising incidence of the aging female population across the globe.
Base Year
Historical Year
Forecast Year
With a robust healthcare and research infrastructure, the United States is poised to lead the female sexual dysfunction treatment market share in the forecast period. The presence of key academic institutions and biopharmaceuticals boosts the market share.
Europe is another significant market with multiple emerging start-ups that function by engaging in new-age technologies like artificial intelligence. Chiaro Technology Ltd., a United Kingdom based company, designed a medical grade-based egg-shaped device that offers biofeedback on pelvic floor muscle contractions with a connection to a mobile app. The development of such devices is a significant indicator of the growing convergence of digital and smart technologies in healthcare and poised to drive the female sexual dysfunction treatment market value in the forecast period.
The shifting cultural dynamics in the Asia Pacific region is expected to drive notable female sexual dysfunction treatment market growth in the future. Several initiatives aimed at spreading awareness and improving female sexual health are on the rise. Moreover, the rising emphasis on improving healthcare infrastructure to merge the latest technologies in the prevailing medical ecosystem is a major factor anticipated to drive market value in the region.
Female Sexual Dysfunction Treatment Market Size
Female Sexual Dysfunction Treatment Market Regional Analysis
Female Sexual Dysfunction Treatment Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is anticipated to grow at a CAGR of 34.20% during the forecast period of 2025-2034, likely to be driven by the increasing incidence of an aging female population across the globe.
The market demand is driven by rapid technological advancements, rising investment in research related activities and drug development, along with growing acceptance of alternative therapies for treating the condition.
The advent of smart devices to facilitate effective solutions to patients is a major market trend. One such example is ‘The Lioness Vibrator 2.0’ which has been developed by a United States based femtech start-up and helps women understand their arousal and sexual response based on data from pelvic muscle contractions.
Based on indication, the market is divided into hypoactive sexual desire disorder (HSDD), arousal disorder, penetration (sexual pain) disorder, and female orgasmic disorder, among others.
Counselling and behavioural therapy, medications, among others are the common treatments available in the market. Medications are divided into non-hormonal therapy and hormonal therapy.
Based on age group, the market is segmented into 18-30 years, 30-45 years, and above 45 years.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are AMAG Pharmaceuticals Inc., Emotional Brain BV, Sprout Pharmaceuticals, Inc., Pivot Pharmaceuticals Inc., Apricus Biosciences, Inc., GlaxoSmithKline, Plc., Pfizer, Inc., Merck & Co., Inc., Cipla Inc., Duchesnay Inc., and Novo Nordisk AS.
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124